Methylphenidate is classified as a Schedule II controlled substance in the United States. This classification indicates that it has a high potential for abuse and dependence but is also recognized for its medical use in treating conditions like attention deficit hyperactivity disorder (ADHD) and narcolepsy. Due to its potential for misuse, it is subject to strict regulatory controls.
Copyright © 2026 eLLeNow.com All Rights Reserved.